Approximately 97% of men with advanced prostate cancer report being comfortable discussing their symptoms with their health care team. But the number of men who actually do so is significantly lower.
Many patients place too high a value on the effectiveness of tumor markers in demonstrating their posttreatment status. Even after offering a detailed explanation of the true worth of these tests, the author's patient still wants to know, "Are you going to order my tumor markers?"
Effective weight management can enhance cancer treatment, improve patient outcomes, and reduce incidence of recurrence and mortality. As with encouraging smoking cessation, oncologists should talk to patients about achieving and maintaining a healthy weight.
Clinical trials could benefit from a greater number of participants with a dedicated cooperative network to support rural community cancer centers.
After participating in a mission trip, an oncology nurse realizes she got more out of her African adventure than she gave to the children of the small village outside Nairobi, Kenya.
Have you ever felt the lasting effect of overhearing an offhand criticism about a clinical decision you made? This nurse reminds her colleagues that they need to advocate for their care as well as their patients.
End-of-life care and decisions can be difficult for health care providers. Consulting the ethics committee can provide needed support for the final decision.
An opportunity to put basic clinical skills to the test demonstrates the depth of nursing skills for this nurse.
The search for the cause of a patient's fatigue and shortness of breath reminded a nurse to remember the little details in the big picture.
A young boy is determined to get the answers to questions about his father's radiation treatments, and the treatment team is happy to oblige.
- Blood Test Predicts Stem Cell Transplant Success in Myelodysplastic Syndrome
- Immunotherapy and the Future of Prostate Cancer Treatment
- Trends in Behaviors, Medical Practice Indicate Mortality From Melanoma Will Decline
- Pembrolizumab Active Against Rare Melanoma, Extends Survival in Bladder Cancer
- Women Treated for DCIS Have Slightly Lower Risk for All-Cause Mortality
- Survivors Reporting Chronic Neuropathic Pain Struggle to Retain Jobs
- Timing of Chemotherapy Infusion Affects Inflammatory Response to Chemotherapy
- Postoperative Gemcitabine Plus Capecitabine: A New Standard of Care for Pancreatic Cancer
- Blood-Forming Stem Cell Transplants (Fact Sheet)
- Nut Consumption Inversely Associated With Lung Cancer Risk
- E-cigarettes and Replacement Nicotine Therapy Safer Than Tobacco Use
- National Health Care Spending Expected to Grow Five Percent Annually
- Patients With Urologic Cancer Need Psycho-oncologic Support to Manage High Stress
- 1 Year of Adjuvant Trastuzumab Improves Long-Term DFS in Early Breast Cancer
- Lenalidomide Maintenance Appears Efficacious for Relapsed DLBCL
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|